BTK Inhibitor Plus Immunotherapy Shows Durable Responses in Relapsed CNS Lymphoma
A prospective phase II trial reports that orelabrutinib combined with sintilimab achieved a 60.7 percent response rate and a median ...
Tag: relapsed refractory lymphoma
B Cell Depletion Marks High-Risk Hodgkin Lymphoma, Spatial Study Finds
A spatial transcriptomics study links depletion of non-tumoral B cells to relapse risk in classical Hodgkin lymphoma and introduces an ...
Adding an Antibody to Venetoclax Deepens Responses in Hard-to-Treat Lymphoma
A French retrospective study of 46 patients with relapsed or refractory Waldenström macroglobulinemia found that venetoclax combined with an anti-CD20 ...
Scientists Uncover B-Cell Lymphoma Characteristics Predicting Optimal Response to CD19 CAR T Cell Therapy
In an unprecedented advancement in lymphoma research, scientists at The University of Texas MD Anderson Cancer Center have unveiled a ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!